European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on November 5, 2026

Nov. 5, 2026

Premier patient traité dans un essai de Phase 1 évaluant BT-001 de Transgene et BioInvent dans le cancer du rectum

Indeterminate GlobeNewswire

Nov. 5, 2026

Ny rapport: En lille EU-regelændring kan frigøre 9,3 milliarder euro i investeringer til cirkulær fosforproduktion

Indeterminate GlobeNewswire

Nov. 5, 2026

Neuer Bericht: Eine geringfügige Änderung der EU-Vorschriften könnte Investitionen in Höhe von 9,3 Milliarden Euro für die kreislauforientierte Phosphorproduktion freisetzen

Indeterminate GlobeNewswire

Nov. 5, 2026

New report: Small EU rule change could unlock 9.3 billion euros in investments for circular phosphorus production

Indeterminate GlobeNewswire

Nov. 5, 2026

Nouveau rapport : une légère modification de la réglementation européenne pourrait débloquer 9,3 milliards d’euros d’investissements dans la production de phosphore recyclé

Indeterminate GlobeNewswire

Nov. 5, 2026

Horwick Presents Its Approach to Multi-Asset Trading Amid Evolving Financial Markets

Indeterminate GlobeNewswire

Nov. 5, 2026

FluoRok シリーズAで3,000万米ドル（2,280万英ポンド）を調達

Indeterminate GlobeNewswire

Nov. 5, 2026

FluoRok, HF를 사용하지 않는 불소화학 제품 제조의 확대를 위해 3,000만 달러(2,280만 파운드) 규모의 시리즈 A 투자 유치

Indeterminate GlobeNewswire

Nov. 5, 2026

WISeQey Advances PKI Modernization as Recent Cyberattacks Highlight the Need to Limit Identity and Credential Risks

Indeterminate GlobeNewswire

Nov. 5, 2026

ArcelorMittal reports third quarter 2026 results

Indeterminate GlobeNewswire

Nov. 5, 2026

Interim Report for Q3 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Wood Mackenzie: One in five refineries at closure risk as global oil demand peaks in 2032

Indeterminate GlobeNewswire

Nov. 5, 2026

Fortuna Reports Results for the Third Quarter 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Step Pharma to present data from ongoing phase 2 clinical trial of dencatistat in essential thrombocythaemia at 68th ASH Annual Meeting

Indeterminate GlobeNewswire

Nov. 5, 2026

Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar

Indeterminate GlobeNewswire

Nov. 5, 2026

HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia

Indeterminate GlobeNewswire